Tirzepatide is a dual GIP and GLP-1 receptor agonist used for the treatment of obesity and diabetes. In lyophilized form, tirzepatide is provided as a freeze-dried powder to extend shelf life and preserve the activity of the peptide.

The powder is reconstituted with a sterile diluent prior to injection. The compounded tirzepatide lyophilized powder you have been prescribed contains the same active pharmaceutical ingredient as brand-name tirzepatide.